| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $14.7M | +1175.0% | +1239.9% |
| R&D Expense | $5.5M | -13.5% | -62.4% |
| SG&A Expense | $29.8M | +9.5% | +91.8% |
| Interest Expense | $5.7M | +0.0% | +5.6% |
| Pre-tax Income | -$163.5M | -20.9% | +46.0% |
| Income Tax | $374K | -49.6% | -42.1% |
| Net Income | -$122.9M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.20B | +30.4% | +133.2% |
| Short-term Investments | $1.18B | +48.8% | +174.1% |
| Accounts Receivable | $11.5M | — | — |
| Inventory | $10.9M | — | — |
| Current Assets | $1.28B | +31.2% | +134.0% |
| Total Assets | $2.55B |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$136.5M | — | — |
| Capital Expenditures | $669.0M | — | — |
| Investing Cash Flow | -$697.0M | — | — |
| Financing Cash Flow | $1.49B | — | — |
| Free Cash Flow | -$805.5M | — | — |
| -23.6% |
| +28.5% |
| +35.6% |
| +210.5% |
| Current Liabilities | $133.6M | +12.9% | +42.0% |
| Long-term Debt | $697.6M | +44.6% | +346.5% |
| Total Liabilities | $924.9M | +27.8% | +190.1% |
| Stockholders' Equity | $1.63B | +40.4% | +223.4% |